SCHEMBL5589592

SCHEMBL5589592

CCCCc1c(O)c(O)c(-c2ccccc2)c(CCCC)c1CCCC

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GCGR P47871 2/20 0.46
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 5/20 0.41
HPGD P15428 4/20 0.41
HSD17B10 Q99714 2/20 0.41
HSD11B1 P28845 1/20 0.41
DCTPP1 Q9H773 1/20 0.40
MAPT P10636 1/20 0.40
PTPN1 P18031 2/20 0.38
LMNA P02545 1/20 0.38
CNR2 P34972 1/20 0.38
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 1/20 0.38
GAA P10253 2/20 0.37
DHFR P00374 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587529 0.89 KDM4E (0.39) GCGRALDH1A1KDM4EHPGDLMNA
SCHEMBL27876741 0.85 GCGR (0.49) GCGRALDH1A1KDM4EHSD17B10HSD11B1
SCHEMBL5589821 0.83 DPP4 (0.45) GCGRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5867520 0.82 GCGR (0.43) GCGRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5589806 0.81 LDHA (0.49) GCGRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL5589600 0.79 PDE4A (0.44) GCGRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL11098791 0.79 ELANE (0.42) GCGRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL28111153 0.78 GCGR (0.58) GCGRHSD11B1TSHRDHFR
SCHEMBL10985993 0.78 GCGR (0.45) GCGRALDH1A1KDM4EHPGDHSD17B10
SCHEMBL546994 0.77 DCTPP1 (0.40) GCGRALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 GCGR 3863/4885ALDH1A1 2181/4885KDM4E 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.